For hepatocellular carcinoma, several serum biomarkers (i.e. Alpha-fetoprotein and its L3 isoform, Protein Induced by Vitamin K Absence-II, Osteopontin...) are currently available in clinical practice, even if their use is not validated nor regulated. Here, AFP is linked to hepatocellular carcinoma.